Clinical trial / 2006
Sugar cane-derived policosanol (10 to 80 mg/d) did not significantly reduce lipid levels compared with placebo.
A 12-week randomized trial assessed the effect of Cuban sugar cane-derived policosanol (10, 20, 40, or 80 mg/d) vs placebo following a 6-week diet and placebo run-in in 143 patients with hypercholesterolemia or combined hyperlipidemia. In none of the five treatment groups did LDL-C decrease by more than 10% from baseline, with no statistically significant differences observed between policosanol and placebo. No significant dose-dependency was detected, and policosanol showed no significant effects on total cholesterol, HDL-C, VLDL-C, triglycerides, lipoprotein(a), or lipid ratios. The treatment was well tolerated without serious adverse events.
- Study type
- Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial
- Who was studied
- 143 patients with hypercholesterolemia or combined hyperlipidemia in Germany
- What was measured
- Percentage change in LDL-C and changes in other lipoproteins
THE PAPER
Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I. JAMA, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.